Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-30T18:28:39.918Z Has data issue: false hasContentIssue false
  • English
  • Français

Platelet Aggregability in Sleep-Related Stroke

Published online by Cambridge University Press:  18 September 2015

C.L. Voll ,
N. Chetty  and
P. Atkinson
C.L. Voll*
Affiliation:
Department of Neurology, University of the Witwatersrand
N. Chetty
Affiliation:
Department of Pathology, SAIMR, Baragwanath Hospital, Johannesburg
P. Atkinson
Affiliation:
Department of Pathology, SAIMR, Baragwanath Hospital, Johannesburg
*
Department of Patholog, University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We examined platelet aggregability during nocturnal sleep and daytime wakefulness in patients with a history of sleep-related stroke onset (SOS) and compared it to that of matched awake-onset stroke (AOS) patients and controls without evidence of vascular disease. Aggregability was evaluated in-vitro at least seven weeks following stroke onset. Platelets were more aggregable to ADP, collagen and arachidonic acid (AA) during both sleep and wakefulness in patients with AOS (p<0.01). No significant difference in the mean aggregation thresholds during sleeping or waking periods were found between SOS and control groups. However, platelets were significantly more responsive to AA during sleep than during wakefulness in the SOS patients (p<0.01). This difference was confined to the subgroup of SOS patients who had experienced nocturnal as opposed to daytime sleep-related stroke onset, suggesting that the observed difference in platelet responsiveness to AA may be related to a circadian fluctuation in platelet aggregability rather than to a sleep-related fluctuation. Significant sleep-related changes in platelet aggregability were not identified in the other two groups.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 16 , Issue 1 , February 1989 , pp. 71 - 77
Copyright
Copyright © Canadian Neurological Sciences Federation 1989

References

REFERENCES

1.Mohr, JP, Caplan, LR, Melski, JW, et al. The Harvard co-operative stroke registry: A prospective registry. Neurology 1978; 28: 754–762.CrossRefGoogle Scholar
2.Caplan, LR, Hier, DB, D’Cruz, I. Cerebral embolism in the Micheal Reese stroke registry. Stroke 1983; 14: 530–536.CrossRefGoogle Scholar
3.Carter, AB. Clinical aspects of cerebral infarction. In: Vinken, PJ, Bruyn, GW, eds. Vascular Diseases of the Nervous System-Part I, Handbook of Clinical Neurology. Amsterdam: North Holland Publishing Company and New York: American Elsevier Publishing Co 1972; 292–326.Google Scholar
4.Adams, RD, Victor, M. Cerebrovascular diseases. In: Barry, BK, Schwarz, M, Scott, EJ, eds. Principles of Neurology. New York: McGraw Hill Book Company 1985; 569–640.Google Scholar
5.Meyer, JS. Summary of the International Round Table Conference on platelet aggregation in the pathogenesis of cerebrovascular disorders. Stroke 1975; 6: 239–244.Google ScholarPubMed
6.Harker, LA, Ritchie, JI. The role of platelets in acute vascular events. Circulation (Suppl 5) 1980; 13–17.Google ScholarPubMed
7.Fleischman, AI, Bierenbaum, ML, Justice, D, et al. In vivo platelet function in acute myocardial infarction, acute cerebrovascular accidents and following surgery. Thromb Res 1975; 6: 205–207.CrossRefGoogle ScholarPubMed
8.Harker, LA, Slichter, J. Arterial and venous thromboembolism: Kinetic characterization and evaluation of therapy. Throm Diath Haemorrh 1974; 31: 188–203.Google ScholarPubMed
9.Uchiyama, S, Takeuchi, M, Osawa, M, et al. Platelet function tests in thrombotic cerebrovascular disorders. Stroke 1984; 14: 511–517.CrossRefGoogle Scholar
10.Cate, JW, Vos, J, Oosterhuis, H, et al. Spontaneous platelet aggregation in cerebrovascular disease. Stroke 1978; 39: 223–229.Google ScholarPubMed
11.Wu, KK, Hoak, JC. Increased platelet aggregates in patients with transient ischemic attacks. Stroke 1975; 6: 521–524.CrossRefGoogle ScholarPubMed
12.Sano, T, Boxer, MGJ, Boxer, LA, et al. Platelet sensitivity to aggregation in normal and diseased groups: A method for assessment of platelet aggregability. Thromb Diath Haemorrh 1971; 25: 524–531.Google ScholarPubMed
13.Dougherty, JH, Levy, DE, Weksler, BB. Platelet activation in acute cerebral ischemia. Serial measurements of platelet function in cerebrovascular disease. Lancet 1977; 1: 821–824.CrossRefGoogle ScholarPubMed
14.Danta, G. Second phase platelet aggregation by adenosine diphosphate in patients with cerebral vascular disease and in normal subjects. Thromb Diath Haemorrh 1979; 23: 159–169.Google Scholar
15.Couch, JR, Hassenein, RS. Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients. Neurology 1976; 26: 888–895.CrossRefGoogle ScholarPubMed
16.Kalendovsky, Z, Austin, J, Steele, P. Increased platelet aggregability in young patients with stroke. Arch Neurol 1975; 32: 13–29.CrossRefGoogle ScholarPubMed
17.Otsuki, Y, Kondo, T, Shio, H, et al. Platelet aggregability in cerebral thrombosis analyzed for vessel stenosis. Stroke 1983; 14: 368–371.CrossRefGoogle ScholarPubMed
18.Fields, WS, Lemak, NA, Frankowski, RF, et al. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301–316.CrossRefGoogle ScholarPubMed
19.Bousser, MG, Escwege, E, Haguenau, M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral infarction. Stroke 1983; 14: 5–14.CrossRefGoogle Scholar
20.Rechtschaffen, A, Kales, A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington: US Government Printing Office, 1968.Google Scholar
21.Born, GVR, Cross, MJ. The aggregation of blood platelets. J Physiol 1963; 168: 179–195.CrossRefGoogle ScholarPubMed
22.Chetty, N, Bradlow, BA. The effects of a vegetarian diet on platelet function and fatty acids. Thromb Res 1983; 30: 619–624.CrossRefGoogle ScholarPubMed
23.Cocherri, S, Fiorentini, P. Platelet adhesiveness and aggregation in hypertensive patients. Acta Med Scand 1971; 525: 273–275.Google Scholar
24.Nubile, G, D’Alonzo, L, Consoli, A, et al. Variazione circadiana dell aggregazione piastrinica indotta da adrenalina e collagene nell’uomo. Boll Soc Ital Biol Sper 1982; 58: 947–950.Google Scholar
25.Tofler, GH, Brezinski, D, Shafer, AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Eng J Med 1987; 316: 1514–1518.CrossRefGoogle ScholarPubMed
26.Sié, P, Perret, B, Cousin, F, et al. Platelet arachidonic acid metabolism in severe cerebrovascular disease. Thromb Res 1982; 28: 1–9.CrossRefGoogle ScholarPubMed
27.Matsumoto, M, Nukada, T, Uyama, O, et al. Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin. Thromb Haemost 1980; 44: 16–22.Google ScholarPubMed
28.Rao, GHR, White, JG. Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation. Am J Hematol 1985; 19: 339–347.CrossRefGoogle ScholarPubMed
29.Parker, DC, Rossman, LG, Kripke, DF, et al. Endocrine rhythms across sleep-wake cycles in normal young men under basal conditions. In: Orem, J, Barnes, CD, eds. Physiology in sleep. Academic Press Inc, New York 1980; 145–179.CrossRefGoogle Scholar
30.Rigas, B, Levine, L. Human salivary eicosanoids: Circadian variation. Biochem Biophys Res Commun 1983; 115: 201–205.CrossRefGoogle ScholarPubMed
31.Couch, JR, Hassenein, RS. Platelet hyperaggregability in multiple sclerosis. Trans Am Neurol Assoc 1977; 102: 62–64.Google ScholarPubMed
32.Neu, I, Prosiegel, M, Pfaffenrath, V. Platelet aggregation and multiple sclerosis. Acta Neurol Scand 1982; 66: 497–504.CrossRefGoogle ScholarPubMed
33.Fredrickson, DS, Levy, RI, Lees, RS. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. N Eng J Med 1967; 276: 149–156.CrossRefGoogle ScholarPubMed